BRIEF-Nicox unveils positive Phase III results for eye drug
September 25, 2014 at 02:18 AM EDT
* Nicox and Valeant Pharmaceuticals announce positive top-line results from pivotal phase 3 studies conducted with Vesneo (latanoprostene bunod)